6th Annual Targeted Protein Degredation (TPD) & Induced Proximity Summit Europe

The 6th Annual Targeted Protein Degredation (TPD) & Induced Proximity Summit Europe focuses on advancing the development of degrader molecules and molecular glues to unlock therapeutic potential for a wide range of diseases.

Topics

• Optimising Drug Development Through Case Studies on Molecular Design & Predictive PK-PD Studies
• Enhancing Structure-Based Design: Predicting Folding & Ternary Complexes
• Leveraging Techniques for Warhead Discovery & Biological Validation of Novel Disease Targets
• Accelerating Molecular Glue Discovery & Development
• Tackling Toxicity, Bioavailability, Dosing & Patient Selection Challenges
• Leveraging Novel MoAs to Unlock New Disease Targets & Realise Therapeutic Potential
• Precision Protein Modulation: Promoting Diverse Pharmacologies
• Advancing Glue Design: Profiling Selectivity, Target Engagement, & Mechanism of Action
• Overcoming Clinical, Funding & Partnership Challenges
• New Frontiers in Targeted Degradation: Advancing Extracellular Matrix & Surface Protein Degraders
• Harnessing Innovative Approaches for the Discovery of Effectors Beyond Cereblon & VHL
• Overcoming Challenges in the Development of Degraders Against Diseases Beyond Oncology

Who should Attend

• Researchers and scientists focused on drug discovery and development
• Professionals in the pharmaceutical and biotechnology industries
• Experts in molecular design, protein degradation, and induced proximity therapeutics
• Clinicians and researchers involved in clinical trials for therapeutic molecules
• Individuals working on disease target identification and validation
• Drug developers and specialists seeking to advance novel therapeutic strategies